Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1998-05-29
1999-10-26
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A61K 3159, C07C40100
Patent
active
059729171
ABSTRACT:
The invention provides 1.alpha.-hydroxyvitamin D compounds in which the C-25 or equivalent position of the C-17 side chain has a double bond and method for their use in the treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders.
REFERENCES:
patent: 4195027 (1980-03-01), DeLuca et al.
patent: 4202829 (1980-05-01), DeLuca et al.
patent: 4225596 (1980-09-01), DeLuca
patent: 4234495 (1980-11-01), DeLuca et al.
patent: 4260549 (1981-04-01), DeLuca et al.
patent: 4341774 (1982-07-01), Aoki et al.
patent: 4388243 (1983-06-01), Nishikawa et al.
patent: 4391802 (1983-07-01), Suda et al.
patent: 4554106 (1985-11-01), DeLuca et al.
patent: 4555364 (1985-11-01), DeLuca et al.
patent: 4652405 (1987-03-01), Pavtridge et al.
patent: 4689180 (1987-08-01), DeLuca et al.
patent: 4749710 (1988-06-01), Truitt et al.
patent: 4891364 (1990-01-01), Kubodera et al.
patent: 5035783 (1991-07-01), Goethals et al.
patent: 5063221 (1991-11-01), Nishii et al.
patent: 5098899 (1992-03-01), Gilbert et al.
patent: 5190935 (1993-03-01), Binderup et al.
patent: 5206229 (1993-04-01), Calverley et al.
patent: 5250523 (1993-10-01), DeLuca et al.
patent: 5252191 (1993-10-01), Pauli et al.
patent: 5304291 (1994-04-01), Bout et al.
patent: 5374629 (1994-12-01), Calverley et al.
patent: 5449668 (1995-09-01), Sestelo et al.
patent: 5518725 (1996-05-01), Daynes et al.
patent: 5540919 (1996-07-01), Daynes et al.
patent: 5559107 (1996-09-01), Gates et al.
patent: 5561123 (1996-10-01), DeLuca et al.
patent: 5562910 (1996-10-01), Daynes et al.
patent: 5585368 (1996-12-01), Steinmeyer et al.
patent: 5589471 (1996-12-01), Hansen et al.
patent: 5665387 (1997-09-01), Mathieu et al.
patent: 5700791 (1997-12-01), Steinmeyer et al.
patent: 5710142 (1998-01-01), Calverley et al.
patent: 5710294 (1998-01-01), DeLuca et al.
patent: 5716946 (1998-02-01), DeLuca et al.
patent: 5750517 (1998-05-01), Baggiolini et al.
patent: 5750746 (1998-05-01), DeLuca et al.
M. F. Holick et al., Proc. Natl. Acad. Sci. USA 68, 803-804 (1971).
G. Jones et al., Biochemistry 14, 1250-1256 (1975).
M. F. Holick et al., Science 180, 190, 191 (1973).
H. Y. Lam et al., Science 486, 1038-1040 (1974).
S. M. Ott, C. H. Chesnut, Annals of Int. Med. 1989, 110:267-274.
J. C. Gallagher et al., Annals of Int. Med. 1990, 113:649-655.
J. Aloia et al., Amer. J. Med. 84:401-08 (1988).
M. Shiraki et al., Endocrinol. Japan 32, 305-315 (1985).
G. F. Jensen et al., Clin. Endocrinol. 16, 515-524 (1982).
C. Christiansen et al., Eur. J. Clin. Invest. 11, 305-309 (1981).
O. H. Sorensen et al., Clin. Endocrinol. 7, 169S-175S (1977).
H. Orimo et al., Bone and Mineral 3, 47-52 (1987).
G. Sjoden et al., J. Nutr. 114, 2043-2046 (1984).
G. Sjoden et al., Proc. Soc. Exp. Biol. Med. 178, 432-436 (1985).
The Merck Index, 11th ed. (1989) p. 9932.
J. Bone Min. Res.; 1994; 9:607-614.
Biochem. J., vol. 310, No. 1 (Aug. 15, 1995) pp. 233-241.
Endocrinology, vol. 136, No. 11 (Nov. 1995) pp. 4749-4753.
Miller et al., 52 Cancer Res. (1992) 515-520.
Skowronski et al., 136 Endocrinology 20-26 (1995).
Horst, R. L., Koszewski, N. J. and Reinhardt, T. A.,Biochem., 29:578-82 (1990).
White et al., 1 J. Chem. Soc. Perkin Trans (1993) 759.
Nishigaichi et al. Chem. Lett. (1996) 961.
Manchand et al., 60 J. Org. Chem. (1995) 6574.
Strugnell et al., Biochem. J., 310: 233-241 (1995).
Bishop Charles W.
Knutson Joyce C.
Strugnell Stephen
Criares Theodore J.
Welch Teresa J.
LandOfFree
1 .alpha.-hydroxy-25-ene-vitamin D, analogs and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1 .alpha.-hydroxy-25-ene-vitamin D, analogs and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1 .alpha.-hydroxy-25-ene-vitamin D, analogs and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764698